SHEPHERD Therapeutics, Inc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From SHEPHERD Therapeutics, Inc
The center is partnering with Obsidian to make autologous TILs work better after being infused back into patients by using IL-15, which may be less toxic than the high-dose IL-2 currently used.
- Digital Health
- Specialty Pharmaceuticals
Drug Discovery Tools
- Drug Discovery Tools